Synaptogenix Inc (SNPX)

[runncoach]

Then maybe read the links I provided for you then or google mild to moderate alzheimer's misdignosis and you can better address my questions. Here's a direct quote from the most recent article I linked to in case the link didn't work for you: "After administering PET scans to 4000 people previously diagnosed with either mild cognitive impairment (MCI) or dementia and treated for Alzheimer’s to test for the presence of amyloid plaque, only 53.3% of patients with MCI and 70.5% with dementia tested positive." That's a whole lot of people who got diagnosed early but DID NOT have alzheimer's.

I can give a list of at least a dozen articles that show roughly 20% or more patients who are diagnosed with alzheimer's, actually don't have the disease. I can link from the AAIC conference, from individual drug companies, etc if you prefer. My math shows me that 20% of 32 patients is between 6 and 7 that wouldn't have the disease. That's mind boggling for an investor who expects a placebo controlled trial.